Clinical trials
Phase 2 Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
| Recruiting | 8 |
| Completed | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Hospital of Shijiazhuang City | 2 |
| Fudan University | 2 |
| Pfizer | 2 |
| Second Affiliated Hospital of Soochow University | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| Xiaoxiang Chen | 2 |
| AstraZeneca | 1 |
| Fujian Cancer Hospital | 1 |
| Guangzhou Medical University | 1 |
| Jinling Hospital, China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 26 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Neoplasms by Histologic Type | 4 |
| Neoplasms by Site | 4 |
| Neoplasms, Glandular and Epithelial | 4 |
| Carcinoma, Hepatocellular | 3 |
| Carcinoma, Ovarian Epithelial | 3 |
| Digestive System Neoplasms | 3 |
| Genital Diseases, Female | 3 |
| Genital Neoplasms, Female | 3 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.